Progress and prospect in tumor treating fields treatment of glioblastoma
Open Access
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111810
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancerLung Cancer, 2013
- Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fieldsWorld Journal of Surgical Oncology, 2012
- Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium StudyJournal of Clinical Oncology, 2011
- TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transportersBMC Cancer, 2010
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United StatesClinical Cancer Research, 2010
- Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungsClinical & Experimental Metastasis, 2009
- Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)BMC Medical Physics, 2009
- A Pilot Study with Very Low-Intensity, Intermediate-Frequency Electric Fields in Patients with Locally Advanced and/or Metastatic Solid TumorsOnkologie, 2008
- Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumorsProceedings of the National Academy of Sciences, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005